BeiGene Canada Fund for Research & Innovation
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline:
External Deadline: Open Call
Description
The BeiGene Canada Fund for Research & Innovation (the BeiGene Canada Fund) is intended to support and enhance research and innovation initiatives related to cancer care in Canada. The fund was designed to leverage financial contributions from other sources including public funding agencies, health charities and other private sector granting sources. For more information on the BeiGene Canada Fund and to apply please click here. To learn more read this article appearing in the Fall 2023 issue of BIOTECanada’s Insights Magazine.
The fund will support projects related to human health research, specifically cancer care, excluding clinical trials. Proposals can fall under the umbrella of any of four themes: biomedical research, clinical research, health systems and services including health policy, and population health. Eligible applicants must be affiliated with a university, college, medical training program, regional health authority, or healthcare or research institution in Canada. The grants will be awarded to the
participating institution and not an individual.
The BeiGene Canada Fund is designed to support innovative research projects for up to two years and
provide a maximum of $50,000 per project ($25,000 per year for 2 years). The fund is not intended to be the sole source of funding for research projects and here is where the partnership concept is realized. The leverage ratio for each research project necessitates matching funding of at
least 1 to 4 in each year (25% of the BeiGene funding). For example, if the Fund provides $40,000 other funding source(s) must provide $10,000. Applications for funding will be accepted on a rolling basis, with no set deadlines, so that researchers and institutions have the flexibility to
align their projects with the evolving landscape of their cancer research.